These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 34643961)
1. Pharmacological Arguments Against the Use of Ketamine in Nonmedical Settings. Green DJ; Masters JC; J Clin Pharmacol; 2022 Jan; 62(1):7-9. PubMed ID: 34643961 [No Abstract] [Full Text] [Related]
3. Promises and concerns regarding the use of ketamine and esketamine in the treatment of depression. Pérez-Esparza R; Kobayashi-Romero LF; García-Mendoza AM; Lamas-Aguilar RM; Fonseca-Perezamador A Acta Psychiatr Scand; 2019 Aug; 140(2):182-183. PubMed ID: 31251388 [No Abstract] [Full Text] [Related]
4. [Psychedelic effects of subanesthetic doses of ketamine]. Zou L; Tian SY; Quan X; Ye TH Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):68-72. PubMed ID: 19317064 [TBL] [Abstract][Full Text] [Related]
5. [Pharmacological modulation of the effects induced by ketamine at subanesthetic doses]. Mechri A; Micallef J; Blin O; Saoud M; Daléry J; Gaha L Therapie; 2001; 56(5):617-22. PubMed ID: 11806303 [TBL] [Abstract][Full Text] [Related]
6. [Ketamine as an NMDA receptor antagonist]. Kushikata T; Hirota K Masui; 2013 Jan; 62(1):38-43. PubMed ID: 23431892 [TBL] [Abstract][Full Text] [Related]
7. A new method to evaluate central sensitization to pain following surgery. Effect of ketamine. Stubhaug A Acta Anaesthesiol Scand Suppl; 1997; 110():154-5. PubMed ID: 9248571 [No Abstract] [Full Text] [Related]
8. Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans. Ilkjaer S; Petersen KL; Brennum J; Wernberg M; Dahl JB Br J Anaesth; 1996 Jun; 76(6):829-34. PubMed ID: 8679358 [TBL] [Abstract][Full Text] [Related]
9. Ketamine as a street drug. Stewart CE Emerg Med Serv; 2001 Nov; 30(11):30, 32, 34 passim. PubMed ID: 11759641 [TBL] [Abstract][Full Text] [Related]
10. Comment on "Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D(2) receptor". Krystal JH; D'Souza DC Biol Psychiatry; 2001 Oct; 50(7):555-6. PubMed ID: 11600110 [No Abstract] [Full Text] [Related]
11. Ketamine for the treatment of depression: what about the addictive potential? Hillemacher T; Bleich S; Demling J; Kornhuber J Aust N Z J Psychiatry; 2007 Sep; 41(9):772-3. PubMed ID: 17896416 [No Abstract] [Full Text] [Related]
12. Ketamine: a controversial drug for neonates. Bhutta AT Semin Perinatol; 2007 Oct; 31(5):303-8. PubMed ID: 17905185 [TBL] [Abstract][Full Text] [Related]
13. Ketamine-A Narrative Review of Its Uses in Medicine. Radvansky BM; Puri S; Sifonios AN; Eloy JD; Le V Am J Ther; 2016; 23(6):e1414-e1426. PubMed ID: 25923225 [TBL] [Abstract][Full Text] [Related]
14. Effects of ketamine on the developing central nervous system. Vutskits L; Gascon E; Kiss JZ Ideggyogy Sz; 2007 Mar; 60(3-4):109-12. PubMed ID: 17451049 [TBL] [Abstract][Full Text] [Related]